Luís Manso
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
-
- Advanced Breast Cancer Therapies
Papers in
- Oncology 80
- Cancer Treatment and Pharmacology 35
- HER2/EGFR in Cancer Research 33
- PARP inhibition in cancer therapy 14
- Cancer Immunotherapy and Biomarkers 9
- Cancer-related Molecular Pathways 6
-
- Advanced Breast Cancer Therapies 32
- Co-authors
- Masakazu Toi (4 shared papers)Matthew P. Goetz (4 shared papers)Mario Campone (4 shared papers)Susana Barriga (2 shared papers)Tammy Forrester (2 shared papers)Olivier Trédan (2 shared papers)Nawel Bourayou (2 shared papers)Jens Huober (2 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Cancer Research (17 papers)Annals of Oncology (10 papers)Clinical & Translational Oncology (7 papers)International Journal of Gynecological Cancer (5 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Luís Manso
130 papers receiving 3.2k citations
Luís Manso's Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.4k
- Cancer Research 527
- Immunology and Allergy 174
- Genetics 223
Countries citing papers authored by Luís Manso
This map shows the geographic impact of Luís Manso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Manso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Manso more than expected).
Fields of papers citing papers by Luís Manso
This network shows the impact of papers produced by Luís Manso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Manso. The network helps show where Luís Manso may publish in the future.
Co-authors
The 25 scholars most cited alongside Luís Manso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer Hit paper breakdown → | 2017 | 1170 |
| 2 | Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial Hit paper breakdown → | 2023 | 514 |
| 3 | 2018 | 224 | |
| 4 | 2006 | 108 | |
| 5 | 2016 | 81 | |
| 6 | 2012 | 74 | |
| 7 | 2023 | 62 | |
| 8 | 2018 | 58 | |
| 9 | 2014 | 52 | |
| 10 | 2018 | 48 | |
| 11 | 2015 | 41 | |
| 12 | 2021 | 39 | |
| 13 | 2018 | 39 | |
| 14 | 2019 | 36 | |
| 15 | 2021 | 35 | |
| 16 | 2021 | 29 | |
| 17 | 2020 | 28 | |
| 18 | 2017 | 27 | |
| 19 | 2022 | 21 | |
| 20 | 2016 | 20 |
About Luís Manso
Luís Manso is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Reproductive Medicine, having authored 139 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (35 papers), HER2/EGFR in Cancer Research (33 papers), Advanced Breast Cancer Therapies (32 papers), Breast Cancer Treatment Studies (16 papers), Ovarian cancer diagnosis and treatment (14 papers), PARP inhibition in cancer therapy (14 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.4k citations), Cancer Research (527 citations), Immunology and Allergy (174 citations) and Genetics (223 citations). Luís Manso has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Masakazu Toi, Matthew P. Goetz, Mario Campone, Susana Barriga, Tammy Forrester, Olivier Trédan, Nawel Bourayou, Jens Huober, Orit Freedman and Angelo Di Leo. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Clinical & Translational Oncology and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.